Paper 3: Lyn activity, DSS colitis, IL-22 Flashcards
1
Q
IL-22 (2)
A
- targets cells in barrier organs, such as intestinal epithelium, where it induces host defence, pro-survival, and proliferation factors
- in colitis injury models, IL-22 antagonizes inflammation and promotes wound healing
2
Q
which cells create IL-22 (3)
A
- T cell subsets
- multiple subsets of ILCs
- production of IL-22 largely influenced by innate immune cells responses to TLR signals
3
Q
Lyn (3)
- protein type
- expression in cells
- activation
A
- Src-family tyrosine kinase (SFK)
- expressed in all leukocytes except T cells
- activated by ligand binding to adhesion molecules, cytokine receptors, immunoreceptors, and TLRs
4
Q
does Lyn amplify or restrict signal transduction
A
- depending on cell microenvironment, developmental stage, and type of stimulus, Lyn can either restrict or amplify signal transduction
5
Q
Lyn^up mice (2)
A
- contain mutation in endogenous Lyn gene at C-terminal negative-regulatory tyrosine phosphorylation site
- leads to increased Lyn activity as inhibition mechanism is altered
6
Q
what was the purpose of figure 1A - 1D
A
- investigate how changes in Lyn activity and associated changes in responses to PAMPs might alter intestinal homeostasis and susceptibility to inflammation
7
Q
what was observed in figure 1A, 1B, 1C
A
- Lyn^up mice were protected from DSS compared with wt (less weight loss, longer colon length, less rectal bleeding)
8
Q
what was observed in figure 1D
A
- Lyn^up mice had fewer crypt loss and less epithelial sloughing and ulceration compared to WT mice
9
Q
what were the findings of figure 1A - 1D
A
- Lyn plays a protective role in DSS-induced colitis
10
Q
what was the purpose of figure 1E - 1I
A
- given Lyn’s protective role in acute colitis, to investigate outcome of chronic inflammation in Lyn^up mice
11
Q
what was observed in figure 1E - 1I
A
- Lyn^up could gain weight in recovery better than wt mice
- Lyn^up mice had reduced morbidity than wt
- Lyn^up mice had significantly longer colons compared to wt, indicated reduced chronic inflammation
- Lyn^up mice had reduced tumour number and load compared to controls
12
Q
what are the findings from figure 1E - 1I
A
- Lyn activity protects mice from acute and chronic DSS-induced intestinal inflammation and reduced incidence of colitis-associated cancer
13
Q
what is the purpose of figure 2
A
- investigate contribution of cytokine responses in Lyn-mediated protection from DSS-colitis
14
Q
how are IL-22 and IL-23 connected
A
- IL-23 drives production of IL-22
15
Q
what was observed in figure 2A, 2B, 2C (2)
A
- Lyn^up colons had significantly more IL-22 and IL-23 protein and mRNA production than wt
- increase seen as early as 2 days post-treatment, with significant increase in colon and detectable increase in serum
16
Q
what was observed in figure 2D
A
- colonic epithelial cells isolated from Lyn^up mice showed consistent increase in STAT3 activation (indicated by phosphorylation of tyrosines), which is done by IL-22
17
Q
what was observed in figure 2E
A
- elevated expression of antimicrobial lectins RegIIIg and RegIIIb and mucus protein Muc1 mRNAs, genes responses to STAT 3 which is induced by IL-22
18
Q
what was observed in figure 2f
A
- no differences in weight change during acute phase of DSS treatment
- IL-22 neutralization resulted in significant delay in recovery of Lyn^up mice
19
Q
what were the findings from figure 2
A
- increased production of IL-22 in Lyn^up mice acts tp enhance intestinal repair and may contribute to protection from DSS colitis